These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12775282)

  • 1. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
    Sennfält K; Carlsson P; Thorfinn J; Frisk J; Henriksson M; Varenhorst E
    Scand J Urol Nephrol; 2003; 37(3):226-31. PubMed ID: 12775282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer--prevalence-based healthcare costs.
    Norlund A; Alvegård T; Lithman T; Merlo J; Noreen D
    Scand J Urol Nephrol; 2003; 37(5):371-5. PubMed ID: 14594683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy.
    Malmberg I; Persson U; Ask A; Tennvall J; Abrahamsson PA
    Urology; 1997 Nov; 50(5):747-53. PubMed ID: 9372886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of prostate cancer, California, 1998.
    Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
    Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of radiotherapy in Sweden.
    Acta Oncol; 1996; 35 Suppl 6():57-71. PubMed ID: 9154086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
    Brandeis J; Pashos CL; Henning JM; Litwin MS
    Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the prostate: an expensive way to die.
    Piper NY; Kusada L; Lance R; Foley J; Moul J; Seay T
    Prostate Cancer Prostatic Dis; 2002; 5(2):164-6. PubMed ID: 12497008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
    Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostatic cancer: an expensive dilemma].
    Borre M; Nerstrøm B; Overgaard J
    Ugeskr Laeger; 1997 Apr; 159(17):2534-7. PubMed ID: 9182381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion and economic consequences of health technologies in prostate cancer care in Sweden, 1991-2002.
    Sennfält K; Carlsson P; Varenhorst E
    Eur Urol; 2006 Jun; 49(6):1028-34. PubMed ID: 16417962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
    Fourcade RO; Benedict A; Black LK; Stokes ME; Alcaraz A; Castro R
    BJU Int; 2010 Jan; 105(1):49-56. PubMed ID: 20132102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I; Pintilie M; Potvin M; McGowan T
    Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer.
    Crawford ED; Black L; Eaddy M; Kruep EJ
    Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):162-7. PubMed ID: 20125121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
    Hallert E; Husberg M; Jonsson D; Skogh T
    Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
    Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
    Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.
    Mouraviev V; Nosnik I; Sun L; Robertson CN; Walther P; Albala D; Moul JW; Polascik TJ
    Urology; 2007 Feb; 69(2):311-4. PubMed ID: 17320670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs in primary care of investigating symptoms suspicious of cancer in a defined population.
    Månsson J; Marklund B; Carlsson P
    Scand J Prim Health Care; 2006 Dec; 24(4):243-50. PubMed ID: 17118865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of bladder tumour treatment and follow-up.
    Hedelin H; Holmäng S; Wiman L
    Scand J Urol Nephrol; 2002; 36(5):344-7. PubMed ID: 12487738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.